Squarepoint’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,415
| Closed | -$396K | – | 3008 |
|
|
2023
Q1 | $396K | Sell |
16,415
-28,484
| -63% | -$686K | ﹤0.01% | 1564 |
|
|
2022
Q4 | $475K | Buy |
+44,899
| New | +$475K | ﹤0.01% | 1477 |
|
|
2021
Q3 | – | Sell |
-18,616
| Closed | -$157K | – | 2937 |
|
|
2021
Q2 | $157K | Buy |
+18,616
| New | +$157K | ﹤0.01% | 2317 |
|
|
2021
Q1 | – | Sell |
-77,301
| Closed | -$1.31M | – | 3203 |
|
|
2020
Q4 | $1.31M | Buy |
+77,301
| New | +$1.31M | 0.01% | 936 |
|
|
2020
Q2 | – | Sell |
-19,282
| Closed | -$177K | – | 2528 |
|
|
2020
Q1 | $177K | Buy |
19,282
+4,120
| +27% | +$37.8K | ﹤0.01% | 1509 |
|
|
2019
Q4 | $226K | Buy |
15,162
+1,252
| +9% | +$18.7K | ﹤0.01% | 2086 |
|
|
2019
Q3 | $95K | Buy |
+13,910
| New | +$95K | ﹤0.01% | 2094 |
|